North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 15 of 15
Details
LDL
Link Added : LANREOTIDE AND OCTREOTIDE - Information for Treatment of Adults with acromegaly or neuroendocrine tumours in Primary Care : http://www.northoftyneapc.nhs.uk/wp-content/uploads/sites/6/2020/02/Lanreotide-and-Octreotide-July-2019-v2.0.pdf
07/06/2021 09:53:30
(DavidS )
UPD
Octreotide updated to clarify what a new patient is
07/06/2021 09:52:19
(DavidS )
UPD
Published from Draft Mode
31/07/2018 10:22:08
(LoweryM )
UPD
Octreotide updated
31/07/2018 10:21:54
(LoweryM )
UPD
Octreotide moved to draft
30/07/2018 15:14:28
(DavidS )
UPD
Octreotide updated to include G+ indication in end of life care. APC approval (JUly 2018)
30/07/2018 15:11:57
(DavidS )
UPD
Octreotide updated
30/07/2018 15:07:34
(DavidS )
UPD
Octreotide updated
19/02/2018 10:17:51
(DavidS )
UPD
Octreotide updated traffic light status
19/02/2018 10:17:27
(DavidS )
UPD
Octreotide formatting
09/03/2017 08:39:10
(DavidS )
UPD
Octreotide updated traffic light status
09/03/2017 08:38:46
(DavidS )
UPD
Octreotide b
25/01/2017 09:42:15
(WhitehallJ )
LDL
Link Added : LANREOTIDE AND OCTREOTIDE – Information for Treatment of Adults with acromegaly or neuroendocrine tumours in Primary Care : http://www.northoftyneapc.nhs.uk/wp-content/uploads/sites/6/2014/03/Lanreotide-and-Octreotide-information-for-primary-
25/01/2017 09:38:13
(WhitehallJ )
UPD
Octreotide b
25/01/2017 09:37:43
(WhitehallJ )
UPD
Octreotide (Sandostatin Lar
®
) build
29/11/2016 09:55:37
(DavidS )